Clinical trials: Chronic Respiratory Failure
Leukemia, Myeloid, Chronic, BCR-ABL Positive
Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance
The purpose of this study is to determine if low-dose imatinib and nilotinib combination, will improve treatment results in CML patients with failure, suboptimal response or intolerance to imatinib therapy.
- Trial name
- NCT01819389
- Testing
- Imatinib and Nilotinib
- Where
- Mexico
- Volunteers
- 10 people
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez